arcalyst - rilonacept injection, powder, lyophilized, for solution
(Rilonacept)Kiniksa Pharmaceuticals (Uk), Ltd.
Usage: Arcalyst treats Cryopyrin-Associated Periodic Syndromes (FCAS and Muckle-Wells Syndrome) in adults and children 12+, maintains remission of IL-1 Receptor Antagonist Deficiency (DIRA) in patients weighing ≥10 kg, and treats recurrent pericarditis to reduce recurrence risk in adults and children 12+.